SHOULD WE REDUCE THE DOSE OF BIOLOGICAL THERAPY TO ALL PATIENTS WITH INFLAMMATORY ARTHRITIS ACHIEVING SUSTAINED THERAPEUTIC GOAL? - Gonzalez-Alvaro, I; Sanchez-Piedra, C; Almodovar, R; Bachiller, J; Balsa, A; Blasco, A J; Caliz, R; Candelas, G; Fernandez-Carballido, C; Garcia-Aparicio, A; Garcia-Magallon, B; Garcia-Vicuna, R; et al. (Annals Of The Rheumatic Diseases, 2017)